Related Experiment Videos
Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura
1Department of Obstetrics and Gynecology, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Insights
Idiopathic thrombocytopenic purpura (ITP) in pregnancy rarely causes infant complications. Most newborns had normal platelet counts, and any drops were manageable, questioning the need for invasive obstetric interventions.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Neonatology
Background:
- Idiopathic thrombocytopenic purpura (ITP) is a condition that can affect pregnant individuals.
- Management of ITP during pregnancy requires careful consideration of maternal and neonatal outcomes.
Purpose of the Study:
- To evaluate the neonatal outcomes in infants born to mothers with confirmed idiopathic thrombocytopenic purpura.
- To assess the predictability of neonatal thrombocytopenia based on maternal factors and interventions.
Main Methods:
- Retrospective analysis of 61 infants born to 50 mothers diagnosed with ITP.
- Monitoring of neonatal cord platelet counts and post-birth platelet levels.
- Evaluation of maternal factors (platelet count, corticosteroid treatment, immunoglobulin G levels, splenectomy) for predictive value.
Main Results:
- None of the 61 infants experienced morbidity or mortality due to thrombocytopenia.
- Only 4.9% of infants had a cord platelet count below 50 x 10(9)/L.
- Maternal factors and fetal scalp platelet sampling were unreliable predictors of neonatal thrombocytopenia.
Conclusions:
- Neonatal outcomes for infants born to mothers with ITP are generally favorable.
- Routine obstetric interventions may not be justified given the low incidence of severe neonatal thrombocytopenia.
- Further research is needed to refine management strategies for ITP in pregnancy.
Abstract:
Idiopathic thrombocytopenic purpura and pregnancy are commonly associated. In this article we describe our experience in the management of 61 infants born to 50 mothers with confirmed idiopathic thrombocytopenic purpura. The focus was the neonatal cord platelet count, the parameter of greatest interest to obstetricians. None of the 61 infants had morbidity or mortality as a consequence of the thrombocytopenia. Only three of 61 infants (4.9%) had a cord platelet count that was less than 50 x 10(9) per liter. Although 66% of the infants had a further fall in the platelet count after birth, in all the thrombocytopenia could readily be corrected. Neither maternal platelet count, maternal treatment with corticosteroids, maternal platelet-associated immunoglobulin G level, nor maternal splenectomy could be used to predict neonatal thrombocytopenia. Fetal scalp platelet sampling was likely to lead to an erroneous decision. The rareness of a poor neonatal outcome raises the question of whether obstetric interventions are justified for every pregnant patient with idiopathic thrombocytopenic purpura.